SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004586
Filing Date
2021-11-15
Accepted
2021-11-15 16:08:03
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adgi-20210930.htm   iXBRL 10-Q 3079590
2 EX-10.1 adgi-ex10_1.htm EX-10.1 240582
3 EX-10.2 adgi-ex10_2.htm EX-10.2 324673
4 EX-31.1 adgi-ex31_1.htm EX-31.1 20546
5 EX-31.2 adgi-ex31_2.htm EX-31.2 21063
6 EX-32.1 adgi-ex32_1.htm EX-32.1 12509
7 EX-32.2 adgi-ex32_2.htm EX-32.2 12503
  Complete submission text file 0000950170-21-004586.txt   9614487

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adgi-20210930_lab.xml EX-101.LAB 401606
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adgi-20210930.xsd EX-101.SCH 50892
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adgi-20210930_cal.xml EX-101.CAL 31201
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adgi-20210930_def.xml EX-101.DEF 180285
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adgi-20210930_pre.xml EX-101.PRE 318132
13 EXTRACTED XBRL INSTANCE DOCUMENT adgi-20210930_htm.xml XML 1449504
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 211410476
SIC: 2836 Biological Products, (No Diagnostic Substances)